UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 24, 2018

 

Alliance BioEnergy Plus,Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   000-54942   45-4944960
(State or Other Jurisdiction
of Incorporation)
  (Commission
File No.)
  (I.R.S. Employer
Identification No.)
         
400 North Congress Avenue, Suite 130, West Palm Beach, FL   77057
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 607-3555

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

   
 

 

TABLE OF CONTENTS

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers
   
Item 9.01 Financial Statements and Exhibits
   
SIGNATURES

 

   
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers

 

On May 24, 2018, the Company’s Board of Directors acted to replace Daniel de Liege as President of the Company with Benjamin Slager (a current director of the Company) who will serve as Interim President with immediate effect to serve until the next election of officers or appointment of his successor. Mr. De Liege will continue to serve on the Board of Directors of the Company.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

None.

 

   
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Alliance BioEnergy Plus, Inc.  
     
By: /s/ Benjamin Slager  
Name: Benjamin Slager  
Title: President  

 

Dated: May 29, 2018